Contact this trialFirst, we need to learn more about you.
Erythropoiesis-Stimulating Agent
KER-050 for Anemia in Myelodysplastic Syndromes
Recruiting1 awardPhase 2
Duarte, California
This trial is testing KER-050, a protein treatment, on patients with low-risk MDS who have low blood cell counts. KER-050 helps the body produce more red blood cells and platelets by blocking signals that slow down their production.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service